Clinical Development of PD-1 Blockade in Hematologic Malignancies.

about

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

Item

http://www.wikidata.org/entity/Q48526801

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

@en

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

@nl

type

Item

label

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

@en

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

@nl

prefLabel

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

@en

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

@nl

P1476

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

@en

P2093

Alexander M Lesokhin

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular mechanisms of T cell co-stimulation and co-inhibition

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

T cell exhaustion

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.

Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

P304

31-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PPO.0000000000000297

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aaron D Goldberg

Matthew J Pianko

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29360725

http://www.w3.org/2001/XMLSchema#string

P932

5785103

http://www.w3.org/2001/XMLSchema#string